Table 1.
Demographic and treatment characteristics of survivors of CNS tumors, solid tumors and siblings
Characteristic | CNS Tumor (n=665) | Solid Tumor (n=1376) | Sibling (n=726) | Pa | Pb | Pc | ||||
---|---|---|---|---|---|---|---|---|---|---|
N (%) | Median (Range) | N (%) | Median (Range) | N (%) | Median (Range) | |||||
Sex | Male | 358 (53.8) | 694 (50.4) | 379 (52.2) | .15 | .54 | .44 | |||
Female | 307 (46.2) | 682 (49.6) | 347 (47.8) | |||||||
Age (Year) | 15.0 (12.0-17.0) | 15.0 (12.0-17.0) | 15.0 (12.0-17.0) | |||||||
Household Income | < 40,000 | 161 (25.8) | 331 (25.9) | 133 (19.3) | .74 | .01 | <.001 | |||
40,000-79,999 | 199 (31.9) | 427 (33.4) | 223 (32.3) | |||||||
>=80,000 | 264 (42.3) | 519 (40.6) | 334 (48.4) | |||||||
Race/Ethnicity | White | 555 (87.0) | 1099 (82.3) | 600 (86.3) | .009 | .56 | <.001 | |||
Black | 31 (4.9) | 122 (9.1) | 28 (4.0) | |||||||
Hispanic | 35 (5.5) | 72 (5.4) | 40 (5.8) | |||||||
Other | 17 (2.7) | 42 (3.1) | 27 (3.9) | |||||||
Diagnosis | Astrocytoma | 382 (57.4) | ||||||||
Medulloblastoma, | 156 (23.5) | |||||||||
PNET | ||||||||||
Other CNS tumors | 127 (19.1) | |||||||||
Neuroblastoma | 703 (51.1) | |||||||||
Wilms Tumor | 673 (48.9) | |||||||||
No cancer | 726 | |||||||||
Age at Diagnosis (Year) | 2.9 (0.0-9.2) | 1.5 (0.0-8.4) | ||||||||
Time Since Diagnosis | 12.1 (8/0- | 13.2 (8.3- | ||||||||
(Year) | 17.7) | 17.9) | ||||||||
CRT | No | 291 (48.3) | 1192 (95.8) | 726 | <.0001 | |||||
Yes | 312 (51.7) | 52 (4.2) | ||||||||
CRT Dose (Gy) | Mean (SD) | |||||||||
Posterior Fossa | 20.3 (25.3) | |||||||||
Temporal Lobe | 23.0 (25.1) | |||||||||
Frontal Cortex | 11.7 (18.0) | |||||||||
Parietal or Occipital | 11.2 (17.6) | |||||||||
Lobe | ||||||||||
Total Dose | 27.0 (26.6) | |||||||||
Decade of Diagnosis | 1970-1989 | 367 (55.94) | ||||||||
1990-1999 | 293 (44.06) | |||||||||
SMN | No | 654 (98.3) | 1355 (98.5) | 726 | 0.83 | |||||
Yes | 11 (1.7) | 21 (1.5) | ||||||||
Relapse | No | 650 (97.7) | 1372 (99.7) | 726 | <.0001 | |||||
Yes | 15 (2.3) | 4 (0.3) |
Abbreviations: CNS, central nervous system; CRT, cranial radiation therapy; SMN, secondary malignancy.
CNS tumor vs.Solid tumor;
CNS tumor vs. Sibling controls;
Solid tumor vs. Sibling controls